Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival. - Wikidata - awgldk - TriplyDB

Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival.

Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival.

http://www.wikidata.org/entity/Q34486859

about

Hormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment Considerations Estrogen receptor beta and ovarian cancer: a key to pathogenesis and response to therapy Prognostic value of progesterone receptor expression in ovarian cancer: a meta-analysis The G-protein-coupled estrogen receptor (GPER/GPR30) in ovarian granulosa cell tumors.Endometriosis and ovarian cancer.The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients.Progesterone action in breast, uterine, and ovarian cancers.Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways.Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients.Active FOXO1 Is a Key Determinant of Isoform-Specific Progesterone Receptor Transactivation and Senescence Programming.The sulfatase pathway for estrogen formation: targets for the treatment and diagnosis of hormone-associated tumors.A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression.Progesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells.Identification of key genes associated with the effect of estrogen on ovarian cancer using microarray analysis.p53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer.Androgen receptor status predicts development of brain metastases in ovarian cancers.Correlation between estrogen receptor expression and prognosis in epithelial ovarian cancer: a meta-analysis.Hormone-receptor expression status of epithelial ovarian cancer in Ibadan, South-western Nigeria.Estrogen receptor promoter methylation predicts survival in low-grade ovarian carcinoma patients.

P2860

Q26751021-C4566944-2881-4D69-8D9D-74810DCB4E0E Q28109453-2B8F5C78-16E8-404A-BF46-2A50007C7FAD Q33829679-D24B8B91-3FCF-4DA1-8659-51B4559FE3F3 Q34358859-C9276AD1-CD4B-496C-BE64-610262261537 Q34657664-E7CE38D8-69FA-42B4-9F23-63CC2A5B5EE5 Q34950615-1EE90DE9-705C-42DD-A3F7-83A2E0AFC3FC Q35108906-1011BA9E-B729-4F5F-AE97-D4373A1C8D3A Q35647617-36E2A5DC-45B2-4F7B-8773-40859AFF8802 Q35659223-C419A49F-0EC0-4232-9FEC-65278FC8A21C Q36586384-A9297FE0-6DF0-4FB3-A63B-D4125C8C0B91 Q36651350-DCC77404-BF22-4FD8-A319-04BABF059437 Q36860111-3B199F78-17F8-4147-BD0C-2B1224F675D1 Q36906210-2B2A5167-21A8-4F0F-8792-E81182FA9257 Q38459223-2D3E8306-316C-4E4F-8B99-2F6C8CB99E13 Q38900869-0B2635C8-591D-420A-A1A6-CA88775194C5 Q41092731-EACC912D-FF8F-4F37-B4DF-6FF619A6F29F Q42365343-617B117E-8A85-4D72-9417-36C43FB66059 Q46747718-EC020E61-27EF-4633-B663-28154154C4D0 Q54204521-CE06C7B5-C98D-429E-BC03-D25E0F2CB4AA

P2860

Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival.

http://www.wikidata.org/entity/Q34486859

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Steroid hormone receptor expre ...... c marker for patient survival.

@ast

Steroid hormone receptor expre ...... c marker for patient survival.

@en

Steroid hormone receptor expre ...... c marker for patient survival.

@nl

type

label

Steroid hormone receptor expre ...... c marker for patient survival.

@ast

Steroid hormone receptor expre ...... c marker for patient survival.

@en

Steroid hormone receptor expre ...... c marker for patient survival.

@nl

prefLabel

Steroid hormone receptor expre ...... c marker for patient survival.

@ast

Steroid hormone receptor expre ...... c marker for patient survival.

@en

Steroid hormone receptor expre ...... c marker for patient survival.

@nl

P1433

Q34486859-6168C95E-B902-48CA-9C87-21AAF03136A9

P1476

Q34486859-789B0EDD-746A-49D6-ABF5-1017AF2692A3

P2093

Q34486859-0FAA66CA-8DA1-40DA-8C51-E9DA1ABB649C

Q34486859-29DB2C04-AAFD-4FA4-B6BC-3935B485BB10

Q34486859-3782BD7B-00A8-4F13-894F-6E5D2850B8A0

Q34486859-750C13AD-F966-4A6A-B6C8-5D6F0E9A4AE3

Q34486859-989C8F35-CB09-4862-8151-50678AC71838

Q34486859-9AB57A8F-1C6E-4B4E-8A91-C3B98D3A406E

Q34486859-B7D89B24-87C6-43F8-A8B0-E77091485F94

Q34486859-E5EC7FE2-94BF-45FF-B11B-AC36A3A997AF

P2860

Q34486859-043A3463-8263-45F6-AB81-431D7B339DA1

Q34486859-1E5F2C39-1031-4F59-8C8E-151F66CA878D

Q34486859-2B924579-6D6D-4D06-A48E-A7FCC851B49E

Q34486859-3B4E7028-9CE4-4256-AF2F-32DA691D8654

Q34486859-45CCCE1D-9B1F-4024-81FE-42EB67A88936

Q34486859-4E51F6F5-1B82-4B69-A1D6-41BE0044B546

Q34486859-51D20F5F-1C9B-4C93-A65A-0A4ED6537CB2

Q34486859-53F8EEE0-E7A8-427F-990C-7E47FAC84A29

Q34486859-664E0BAD-03ED-4152-B4BB-804378B6CB94

Q34486859-669728C8-E258-4C3A-AFA3-626CC0B6663C

P2888

Q34486859-86D1D318-2F8E-403B-BDA6-32B19C1A2588

P304

Q34486859-FC7F7681-1C84-46BA-AB46-768CC8D26BA6

P31

Q34486859-19D274E0-4C80-47DF-868A-216F2E8AE14E

P356

Q34486859-8862C98F-BB0C-4EC6-A95E-1C1FF391F2FB

P407

Q34486859-B696575E-F612-4EA6-B752-A5386DB27854

P478

Q34486859-0BB24AD7-3505-487F-AA8E-0D0BF69DCC47

P577

Q34486859-36F3DF65-472D-4053-A8C5-A262FFD739AE

P5875

Q34486859-75178625-2FED-43BA-97D0-18679FEA9CE6

P6179

Q34486859-45BA2ACC-D28D-4FF8-AB14-C8B90B7EDB92

P698

Q34486859-42D5EAA5-F537-4C94-9C00-A2E868766534

P921

Q34486859-B56F8323-D29C-4F52-BC4E-012A556B7D05

Q34486859-B901016A-61FA-4321-8ED1-131BEFBA1168

P932

Q34486859-077A830F-8062-448A-9776-C0C7530A1884

P356

1471-2407-12-553

P1433

P1476

Steroid hormone receptor expre ...... c marker for patient survival.

@en

P2093

Doris Mayr

http://www.w3.org/2001/XMLSchema#string

Isabelle Himsl

http://www.w3.org/2001/XMLSchema#string

Klaus Friese

http://www.w3.org/2001/XMLSchema#string

Lennerová Tereza

http://www.w3.org/2001/XMLSchema#string

Miriam Lenhard

http://www.w3.org/2001/XMLSchema#string

Nina Ditsch

http://www.w3.org/2001/XMLSchema#string

Sabine Heublein

http://www.w3.org/2001/XMLSchema#string

Udo Jeschke

http://www.w3.org/2001/XMLSchema#string

P2860

Tamoxifen for relapse of ovarian cancer

A transmembrane intracellular estrogen receptor mediates rapid cell signaling

G protein-coupled estrogen receptor 1/G protein-coupled receptor 30 localizes in the plasma membrane and traffics intracellularly on cytokeratin intermediate filaments

Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B

Detection of progesterone receptor forms A and B by immunohistochemical analysis

Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum.

Use of tamoxifen in asymptomatic patients with recurrent small-volume ovarian cancer.

Loss of ERbeta expression as a common step in estrogen-dependent tumor progression

Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies

LH/hCG action and development of ovarian cancer--a short review on biological and clinical/epidemiological aspects.

P2888

1471-2407-12-553

P304

553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-12-553

http://www.w3.org/2001/XMLSchema#string

P407

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233766471

http://www.w3.org/2001/XMLSchema#string

P6179

1017595770

http://www.w3.org/2001/XMLSchema#string

P698

23176303

http://www.w3.org/2001/XMLSchema#string

P921

P932

3575289

http://www.w3.org/2001/XMLSchema#string